Početna › Neuroblastom › Massachusetts › Boston

Kliničke studije za Neuroblastom u gradu Boston, MA

13 studija za Neuroblastom traži sudionike na lokacijama u gradu Boston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

U tijeku regrutacijaFaza 3

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Do 30 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06172296

MCT for the Harvard/UCSF ROBIN Center

U tijeku regrutacija

Brigham and Women's Hospital, Boston

Sve dobne skupine · Oba spola · Ažurirano 1. lis 2026. · NCT06000787

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

U tijeku regrutacijaFaza 1/2

Dana-Farber Cancer Institute ( Site 1013), Boston

6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103

B7-H3.CD28Z.CART in Solid Tumors

U tijeku regrutacijaFaza 1

Dana Farber Cancer Institite, Boston

9 Months – 30 Years · Oba spola · Ažurirano 3. ruj 2026. · NCT07358260

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

U tijeku regrutacijaFaza 3

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

365 Days – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

U tijeku regrutacijaFaza 1/2

Dana-Farber Cancer Institute, Boston

12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

SPEARHEAD-3 Pediatric Study

U tijeku regrutacijaFaza 1/2

Dana Farber Cancer Institute, Boston

Od 2 do 21 godina · Oba spola · Ažurirano 11. kol 2026. · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

U tijeku regrutacijaFaza 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Od 1 do 30 godina · Oba spola · Ažurirano 22. srp 2026. · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

U tijeku regrutacijaFaza 2

Boston Children's Hospital, Dana-Farber Cancer Institute., Boston

Od 1 do 31 godina · Oba spola · Ažurirano 20. srp 2026. · NCT06450041

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

U tijeku regrutacijaFaza 1

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Od 1 do 30 godina · Oba spola · Ažurirano 14. srp 2026. · NCT07027748

Neuroblastoma Biology Study

U tijeku regrutacijaOpažajna studija

Children's Hospital Boston, Boston

31 Days – 99 Years · Oba spola · Ažurirano 23. ožu 2026. · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

U tijeku regrutacija

Dana-Farber Cancer Institute, Boston

Do 17 godina · Oba spola · Ažurirano 10. velj 2026. · NCT06831552

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

U tijeku regrutacijaFaza 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

12 Months – 29 Years · Oba spola · Ažurirano 26. pro 2025. · NCT06803875

Studije za Neuroblastom u drugim gradovima

Ostale studije u gradu Boston

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.